首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Adrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of rats.
【2h】

Adrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of rats.

机译:阿托品样药物山iso碱和山iso碱对大鼠脑和心血管组织的肾上腺素受体阻断特性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cholinoceptor antagonists anisodamine and anisodine are widely used in the People's Republic of China for the management of acute circulatory shock but the mechanism of their beneficial effects is not fully known; we therefore investigated if these agents possessed adrenoceptor blocking properties. The antagonistic effect of anisodamine and anisodine against the specific binding of the alpha 1-adrenoceptor ligand [3H]-WB-4101 to cardiac and brain tissue membrane preparations and against the effects of phenylephrine on isolated aortic strips and left atria of rats were compared with classical muscarinic receptor and adrenoceptor blocking agents. Both anisodamine and anisodine possessed alpha 1-adrenoceptor blocking properties; the order of potency of various agents in displacing the binding of [3H]-WB-4101 to receptors and in antagonizing the effects of phenylephrine on aortic strips and left atria was: prazosin greater than atropine greater than anisodamine greater than scopolamine greater than anisodine. It is concluded that both anisodamine and to a lesser extent anisodine possess alpha 1-adrenoceptor blocking properties; this antagonistic activity of anisodamine may contribute to its salutary effects on the microcirculation. However, it is unlikely that anisodine produces a significant adrenoceptor blockade in the clinically used dose-range.
机译:胆碱受体拮抗剂山iso碱和山iso碱在中华人民共和国被广泛用于急性循环休克的治疗,但其作用机理尚不清楚。因此,我们研究了这些药物是否具有肾上腺素受体阻断特性。比较了山iso碱和山iso碱对α1-肾上腺素受体配体[3H] -WB-4101与心脏和脑组织膜制剂的特异性结合的拮抗作用以及苯肾上腺素对大鼠离体主动脉条和左心房的拮抗作用。经典毒蕈碱受体和肾上腺素受体阻断剂。山iso碱和山iso碱均具有α1-肾上腺素受体阻滞特性。各种药物在取代[3H] -WB-4101与受体的结合以及拮抗苯肾上腺素对主动脉条和左心房的作用方面的效力顺序为:哌唑嗪大于阿托品大于山iso碱大于东碱大于东iso碱。结论是,山iso碱和较小程度的山iso碱均具有α1-肾上腺素受体阻滞性质。山iso胺的这种拮抗活性可能有助于其对微循环的有益作用。但是,山iso碱不太可能在临床使用的剂量范围内产生明显的肾上腺素受体阻滞剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号